Pulmonx Corp (LUNG)

R&D Expenses

$5.03M

Quarterly · Period ending: · USD

LUNG logo

LUNG R&D Expenses

Latest reported$5.03M
LUNG Quarterly R&D Expenses ($1.52M → $5.03M)
High-resolution chart · PNG

LUNG r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pulmonx Corp R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
5,034,000
4,899,000
4,583,000
4,846,000
5,306,000
4,756,000
4,001,000
3,744,000
5,615,000
4,210,000
3,896,000
4,220,000
5,710,000
4,253,000
3,903,000
4,366,000
3,594,000
3,534,000
3,708,000
2,815,000
3,506,000
3,034,000
2,472,000
1,997,000
1,426,000
1,565,000
1,603,000
1,399,000
1,452,000
1,523,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.